201 results on '"De Placido, Pietro"'
Search Results
2. Central obesity, body mass index, metabolic syndrome and mortality in Mediterranean breast cancer patients
3. Analysis of circulating extracellular vesicle derived microRNAs in breast cancer patients with obesity: a potential role for Let-7a
4. Evolving treatments and outcomes in HER2-Positive metastatic breast cancer: Data from the GIM14/BIOMETA study
5. Impaired Seroconversion After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA Vaccine in Patients With Thymic Epithelial Tumors
6. The evolving therapeutic landscape of trastuzumab-drug conjugates: Future perspectives beyond HER2-positive breast cancer
7. Inadequate health-related quality of life assessment and reporting in phase III clinical trials of immune checkpoint inhibitors in solid cancers: A systematic review
8. Exploring the interplay between Kaposi's sarcoma and SARS‐CoV‐2 infection: A case series and systematic review.
9. Case report: Potential role of immunotherapy in thymic malignancies: a unique case of a durable and complete response upon an immune checkpoint inhibitor.
10. Serum biomarkers of inflammation and vascular damage upon SARS-Cov-2 mRNA vaccine in patients with thymic epithelial tumors
11. Assessment of Total, PTEN–, and AR-V7+ Circulating Tumor Cell Count by Flow Cytometry in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Enzalutamide
12. A review of the use of next generation sequencing methodologies to identify biomarkers of resistance to CDK4/6 inhibitors in ER+/HER2- breast cancer
13. Ductal Carcinoma In Situ
14. Mechanisms of resistance to mTOR inhibitors
15. Optimising triage procedures for patients with cancer needing active anticancer treatment in the COVID-19 era
16. AB012. The potential role of innate lymphoid cells in thymic epithelial tumors
17. AB003. Unexpected long-lasting control of thymic carcinoma treated with anti-PD1 and oral etoposide: a real-life experience of combination therapy
18. AB013. Occurrence and severity of COVID-19 in patients affected by thymic epithelial tumors with or without Good’s syndrome: a single centre experience
19. miRNAs in the Box: Potential Diagnostic Role for Extracellular Vesicle-Packaged miRNA-27a and miRNA-128 in Breast Cancer
20. Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysis
21. Immunocytometric analysis of patients with thymic epithelial tumors revealed that COVID-19 vaccine booster strongly enhanced the immune response
22. Central Obesity, Body Mass Index, Metabolic Syndrome and Mortality in Mediterranean Breast Cancer Patients
23. The effect of the alpha-specific PI3K inhibitor alpelisib combined with anti-HER2 therapy in HER2+/PIK3CA mutant breast cancer
24. Incidence of fatigue and low-dose corticosteroid use in prostate cancer patients receiving systemic treatment: a meta-analysis of randomized controlled trials
25. Glucocorticoid Receptor and Ovarian Cancer: From Biology to Therapeutic Intervention
26. Shifting from a Biological-Agnostic Approach to a Molecular-Driven Strategy in Rare Cancers: Ewing Sarcoma Archetype
27. Multidisciplinary approach for rare thoracic tumors during COVID-19 pandemic
28. The European Reference Network: the keystone for the management of rare thoracic cancers
29. Extraskeletal Ewing’s sarcoma of the mediastinum: Case report
30. Multiple Bayesian network meta-analyses to establish therapeutic algorithms for metastatic triple negative breast cancer
31. The unusual first sign of presentation of renal cell carcinoma: a rare case report
32. Overall survival benefit in clinically relevant subgroups for CDK4/6 inhibitors combined with endocrine therapy in metastatic breast cancer: a meta-analysis
33. Efficacy of endocrine- versus chemotherapy-based treatments in hormone receptor-positive, HER2-negative postmenopausal metastatic breast cancer: a Network Meta-Analysis
34. Insight on the Role of Leptin: A Bridge from Obesity to Breast Cancer
35. Safety and immunogenicity of the COVID-19 vaccine BNT162b2 for patients with breast and gynecological cancer on active anticancer therapy: Results of a prospective observational study
36. Immunological signature of patients with thymic epithelial tumors and Good syndrome
37. FOLFIRINOX or nab-paclitaxel plus gemcitabine in metastatic pancreatic adenocarcinoma: an observational study
38. Impaired seroconversion after SARS-COV-2 mRNA vaccine in patients with thymic epithelial tumors.
39. Immunological signature of patients with thymic epithelial tumors.
40. Prevalence of Sarcopenia in Women with Breast Cancer
41. The Never-Ending History of Octreotide in Thymic Tumors: A Vintage or A Contemporary Drug?
42. AB009. Pitfalls in mediastinal masses diagnosis
43. AB010. Incidental discovery of thymic masses during syndrome coronavirus type 2 (SARS-CoV-2) infection
44. AB008. Synchronous thymic and breast malignancies: a single institutional experience
45. AB007. Preliminary data of immunogenicity of SARS-COV-2 mRNA vaccine in thymic epithelial tumors
46. Use of FOLFIRINOX or Nab-Paclitaxel Plus Gemcitabine for the Treatment of Locally Advanced Pancreatic Adenocarcinoma: A Single Institution Observational Study
47. A risk-group classification model in patients with bladder cancer under neoadjuvant cisplatin-based combination chemotherapy
48. Pneumonitis in patients with thymoma and Good's syndrome.
49. Three vs. Four Cycles of Neoadjuvant Chemotherapy for Localized Muscle Invasive Bladder Cancer Undergoing Radical Cystectomy: A Retrospective Multi-Institutional Analysis
50. Endocrine-Based Treatments in Clinically-Relevant Subgroups of Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Systematic Review and Meta-Analysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.